Education
About Us
Working with TipRanks
Follow Us
Richard M Glickman Insider Profile
4 Followers
Richard M Glickman, Chairman & Chief Executive Officer at Aurinia Pharmaceuticals, holds 1.13M shares in Aurinia Pharmaceuticals (Ticker: AUPH), holds 14.44K shares in Correvio Pharma (Ticker: CORV), holds 47.95K shares in ESSA Pharma (Ticker: EPIX). Most recently, Richard M Glickman ― shares of Aurinia Pharmaceuticals on ― for an estimated value of ―.
Richard M Glickman Aurinia Pharmaceuticals (AUPH)Chairman & Chief Executive Officer
Aurinia Pharmaceuticals (AUPH)
Chairman & Chief Executive Officer
Ranked #75,531 out of 104,058 Corporate Insiders
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-28.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Richard M Glickman holds in companies
Most Profitable Insider Trade
The most profitable trade made by Richard M Glickman
Richard M Glickman's Trading History
Aurinia Pharmaceuticals
―
Chairman & Chief Executive Officer
―
$13.44M
Correvio Pharma
―
―
―
$6.05K
ESSA Pharma
―
―
―
$9.64K
Eupraxia Pharmaceuticals
Oct 01, 2025
Director
Informative Buy
27.11K
C$145.22K
List of latest transactions for each holding click on a transaction to see Richard M Glickman's performance on stock
You May Also Like
Richard M Glickman insider profile FAQ
What is the percentage of profitable transactions made by Richard M Glickman?
The percentage of profitable transactions made by Richard M Glickman is 0%.
What is the average return per transaction made by Richard M Glickman?
The average return per transaction made by Richard M Glickman is -28.10%.
What stocks does Richard M Glickman hold?
Richard M Glickman holds: AUPH, CORV, EPIX, TSE:EPRX stocks.
What was Richard M Glickman’s latest transaction?
Richard M Glickman latest transaction was an Uninformative Buy of ―.
What was Richard M Glickman's most profitable transaction?
Richard M Glickman’s most profitable transaction was an Informative Buy of TSE:EPRX stock on October 1, 2025. The return on the trade was -4.40%.
What is Richard M Glickman's role in Aurinia Pharmaceuticals?
Richard M Glickman's role in Aurinia Pharmaceuticals is Chairman & Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.